Bioinspired by tunicates and mussels, a Korean research team has created a “bomb-like” anticancer therapeutic agent that only destroys cancer cells.
The nanobomb produces heat in precise sites where near-IR (NIR) laser is irradiated to create nitric oxide gas, which has an anticancer effect and concurrently discharges anticancer drugs to accomplish the trimodal treatment of photothermal-gas-chemo-therapy.
The POSTECH research team was headed by Professor Hyung Joon Cha and Dr. Yeonsu Jeong (Department of Chemical Engineering) in partnership with Professor Yun Kee Jo’s team at Kyungpook National University (Department of Biomedical Convergence Science and Technology, School of Convergence).
The researchers engineered a photoactivatable adhesive nanobomb with mussel adhesive proteins (MAPs) and the catechol-vanadium complex of tunicates that involves light-associated energy conversion through electron transfer. The term ‘photoactivatable’ denotes the characteristic where properties vary based on the external light.
Since cancer manifests via multiple biological pathways, a process that integrates several treatments rather than one single treatment is generally employed. But it is challenging to deliver several therapeutic agents at once to a particular cancer site because of the large amount of fluid found in the human body.
Among such approaches, light-triggered photothermal therapy (PTT) employs nanoparticles of metals, synthetic polymers or carbon. However, their weak biodegradability, which can cause a hazard of systemic toxicity, and low photothermal conversion efficiency — the efficiency at which the captured light is turned to heat — render effective cancer treatment tough.
To this, the researchers developed nanoparticles by incorporating the catechol-vanadium complexes — which help electrons and light travel in tunicates — to the MAP. When these nanoparticles are exposed to the light from NIR lasers, the temperature can be increased to 50 degrees within 5 minutes, displaying exceptional photothermal conversion efficiency of around 50%.
These nanoparticles can be retained on cancer cells for an extended period owing to the robust adhesiveness of MAP. Furthermore, the excellent biocompatibility and biodegradability of proteinic nanoparticles resolve the safety matter of traditional light-responsive nanotherapeutics.
When the nanoparticles comprising a thermo-sensitive nitric oxide (NO) donor and an anticancer drug were irradiated using the near-IR (NIR) laser, NO gas and drugs were effectively discharged due to the photothermal effect, verifying their likelihood for use in a nanobomb.
It is generally tough to retain the anticancer effects of NO gas as it rapidly biometabolizes. However, the nanobomb can regulate the release of gas with light, which significantly raises the delivery efficiency of NO.
In preclinical testing in animal models, the tumor grew back 15 days after being treated with only a single photothemal treatment, whereas the therapeutic effectiveness was extended with trimodal treatments using nanobombs as no tumors were seen for around 1 month.
With a single nanoparticle, various site-specific therapeutic agents can be locally administered and multimodal treatments can be easily controlled with a single stimulus, which will be effective in treating cancer patients in the future.
Professor Hyung Joon Cha, Department of Chemical Engineering, Pohang University of Science and Technology
“This nanobomb can be applied not only to photothermal-gas-chemo-therapy, but also to the delivery of therapeutics including genes and antibodies or contrast agents, and therefore can be widely used according to the specific needs of the patient or the condition,” Professor Hyung Joon Cha added.
This research was chosen as the front cover paper of the December issue of Advanced Healthcare Materials, a well-known journal in the domain of materials science.
The research was performed with the support from the National Research Foundation grant funded by the Ministry of Science and ICT of Korea, the National Research Foundation grant funded by the Ministry of Education of Korea, and the Marine BioMaterials Research Center grant funded by the Ministry of Oceans and Fisheries of Korea.
The mussel adhesive protein technology has gone through a technology transfer to Nature Glutech Co., Ltd., and clinical trials will take place after procuring investigational new drug (IND) approvals.
News
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
